Searched for
DRS PHARMA
Stock market update: Nifty Pharma index advances 0.76%The Nifty Pharma index closed 0.76 per cent up at 12274.35.- Stock market update: Nifty Pharma index advances 0.42% in an upbeat marketThe Nifty Pharma index was trading 0.42 per cent up at 12232.6.
- Stock market update: Nifty Pharma index advances 0.94%The Nifty Pharma index closed 0.94 per cent up at 12181.85.
- Stock market update: Nifty Pharma index advances 1.04%The Nifty Pharma index closed 1.04 per cent up at 11754.7.
- Stock market update: Stocks that hit 52-week highs on NSE in today's tradeDRS Dilip Roadlines, Chaman Lal Setia, Vardhman Special, RM Drip and Sprinkle and Arrow Greentech, hit their fresh 52-week highs during the...
- Stock market update: Stocks that hit 52-week lows on NSE in today's tradeBPCL, NTPC, Coal India Ltd, Adani Ports SEZ and Axis Bank were among the top losers on NSE in today's trade.
- Stock market update: Nifty Pharma index advances 0.17% in an upbeat marketThe Nifty Pharma index was trading 0.17 per cent up at 11653.35.
- Stock market update: Nifty Pharma index falls 0.42%The Nifty Pharma index closed 0.42 per cent down at 11700.4.
- Stock market update: Nifty Auto index falls 0.33% in a weak marketThe Nifty Auto index was trading 0.33 per cent down at 12917.8.
- Stock market update: Nifty IT index falls 0.73% in a weak marketThe Nifty IT index was trading 0.73 per cent down at 30094.35.
- Stock market update: Stocks that hit 52-week lows on NSEAdani Ports SEZ, Apollo Hospital, IndusInd Bank, SBI and Adani Ent. were among the top losers on NSE.
- Stock market update: Stocks that hit 52-week highs on NSEDRS Dilip Roadlines, Radhika Jeweltech, Lambodhara Text, Servotech Power Syst and Upsurge Seeds of Agriculture Ltd., hit their fresh 52-wee...
- Stock market update: Nifty Pharma index falls 1.0% in a weak marketThe Nifty Pharma index was trading 1.0 per cent down at 12468.3.
- Buy Divi's Laboratories, target Rs 1,675: Manas JaiswalBuy Divi's Laboratories Ltd. at a price target of Rs 1675.0 and a stoploss at Rs 1615 from entry point.
- Buy Divi's Laboratories Ltd. target Rs 1675 : Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1675.0 and a stoploss at Rs 1610 from entry point.
- Buy Divi's Laboratories, target Rs 1,724: Kunal BothraBuy Divi's Laboratories Ltd. at a price target of Rs 1724.0 and a stoploss at Rs 1677 from entry point.
- Tata Motors lone indian among top global R&D spendersThe Government of India’s Economic Survey 2017-18 has called for doubling of national expenditures on R&D.
- Government notifies norms of composite cap to simplify FDIGovernment has notified the norms of composite caps for simplifying the foreign direct investment (FDI) policy, approved by the Union cabin...
- Government signs pact to revive Indian Drugs and Pharmaceuticals Ltd, to provide need-based fundsDraft Rehabilitation Scheme (DRS) for revival of IDPL has been submitted and cabinet note for revival is on process.
- DRS Group forays into pharmaThe Rs 450-crore DRS transport-to-logistics group is actively pursuing its diversification plans. Eight years since it ventured into the re...
Load More
